You may be eligible to participate in the BRAVOS Study if you:
- Are 18-70 years old
- Have been diagnosed with diffuse cutaneous systemic sclerosis (dcSSc)
- Have had dcSSc for 5 or fewer years
- Have been taking one of the following medications for at least 3 months: methotrexate (Trexall® or Rasuvo®) or mycophenolate mofetil (CellCept®) or azathioprine (Imuran® or Azasan®)
To learn more about this study, visit clinicaltrials.gov.